reset
Close search icon

Cambridge Oncometrix

Cambridge Oncometrix develops a non-invasive prostate liquid biopsy test for men suspected of prostate cancer. The test is based on proprietary biomarkers and will identify men who will benefit from prostate biopsy and those who can safely forgo it.

Shape banner Shape banner Shape banner

Recent News

News main image

29 June 2022

What sea cucumbers can teach us about self-defence

Read more
News main image

29 June 2022

Three key ingredients for business success – the lessons learned from biotech

Read more

Recent Event

News main image

Sunday, 31/07/2022 13:00

Celebrating 250 years of NNUH at Bishop’s House Open Garden, Norwich

Read more